Hospital Infection Therapeutics Market to Reach US$ 17.8 Bn by 2026

Š2019 Transparency Market Research, All Rights Reserved

Hospital Infection Therapeutics Market Therapeutics - Anti-bacterial Drugs, Anti-fungal Drugs, Anti-viral Drugs; Infection - Hospital Acquired Pneumonia, Urinary Tract Infections, Gastrointestinal Disorders, Bloodstream Infections, Surgical Site Infections, Other Hospital Infections - Forecast 2018 - 2026

Š2019 Transparency Market Research, All Rights Reserved

Š2019 Transparency Market Research, All Rights Reserved

Table of Content Sr. No.

Content

Chapter1

Preface

Chapter 2

Assumptions and Research Methodology

Chapter 3

Executive Summary: Global Hospital Infection Therapeutics Market

Chapter 4

Market Overview

Chapter 5

Market Outlook

Chapter 6

Global Hospital Infection Therapeutics Market Analysis and Forecast, by Therapeutics

Chapter 7

Global Hospital Infection Therapeutics Market Analysis and Forecasts, by Infection

Chapter 8

Global Hospital Infection Therapeutics Market Analysis and Forecasts, by Region

Chapter 9

North America Hospital Infection Therapeutics Market Analysis and Forecast

Chapter 10

Europe Hospital Infection Therapeutics Market Analysis and Forecast

Chapter 11

Asia Pacific Hospital Infection Therapeutics Market Analysis and Forecast

Chapter 12

Latin America Hospital Infection Therapeutics Market Analysis and Forecast

Chapter 13

Middle East & Africa Hospital Infection Therapeutics Market Analysis and Forecast

Chapter 14

Competition Landscape

©2019 Transparency Market Research, All Rights Reserved

Hospital Infection Therapeutics Market: Snapshot •

This report studies the current as well as future prospects of the global hospital infection therapeutics market.

•

Increase in the geriatric population which is more prone to hospital-acquired infections, significant patient population in developing countries demanding proper treatment, and investments by public and private players for R&D on anti-infective drugs against resistant bacteria are the major factors driving the global hospital infection therapeutics market.

•

Major players operating in the global hospital infection therapeutics market are Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline plc, AstraZeneca, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Allergan plc.

©2019 Transparency Market Research, All Rights Reserved

Š2019 Transparency Market Research, All Rights Reserved

Š2019 Transparency Market Research, All Rights Reserved

©2019 Transparency Market Research, All Rights Reserved

Reports Highlights • global hospital infection therapeutics market was valued at US$ 14.4 Bn in 2017 and is projected to expand at a significant CAGR of 2.4% from 2018 to 2026.

• Based on infection, the global hospital infection therapeutics market has been divided into hospital acquired pneumonia, surgical site infections, bloodstream infections, gastrointestinal disorders, urinary tract infections, and other hospital infections.

•

Increase in R&D to Develop Novel Antibiotics to Boost Market

•

Hospital acquired as well as community-associated infections due to highly resistant microbes present a major threat to public health.

©2019 Transparency Market Research, All Rights Reserved

Request Sample

Š2019 Transparency Market Research, All Rights Reserved

To know more about us, please visit our website:

www.transparencymarketresearch.com For sales queries or new topics email us on:

sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030

T

H

A Y

N O

K U